Damora Therapeutics
DMRA
#5530
Rank
A$2.13 B
Marketcap
A$34.50
Share price
-1.35%
Change (1 day)
30.04%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -A$0.39 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.31 Billion a decrease over its 2024 earnings that were of -A$31.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.39 Billion27.69%
2025 -A$0.31 Billion880.41%
2024 -A$31.09 Million-44.2%
2023 -A$55.72 Million-37.77%
2022 -A$89.53 Million19.08%
2021 -A$75.19 Million48.55%
2020 -A$50.62 Million